Prelude Therapeutics IncNASDAQ:PRLD
- LAST PRICE1.1500
- TODAY'S CHANGE (%)-0.0400 (-3.3613%)
- Bid / Lots1.1200/ 10
- Ask / Lots1.1500/ 59
- Open / Previous Close1.2000 / 1.1900
- Day Range
- 52 Week Range
- Volume537,198
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PRLD |
|---|---|---|
| 09:32 ET | 7801 | 1.2 |
| 09:33 ET | 200 | 1.195 |
| 09:35 ET | 100 | 1.19 |
| 09:37 ET | 1000 | 1.2008 |
| 09:39 ET | 10685 | 1.2 |
| 09:42 ET | 1100 | 1.2176 |
| 09:44 ET | 1300 | 1.195 |
| 09:46 ET | 2000 | 1.2085 |
| 09:48 ET | 100 | 1.195 |
| 09:53 ET | 802 | 1.19 |
| 09:55 ET | 329 | 1.2 |
| 09:57 ET | 1885 | 1.19 |
| 10:00 ET | 10817 | 1.18 |
| 10:02 ET | 100 | 1.2 |
| 10:06 ET | 1404 | 1.1966 |
| 10:08 ET | 100 | 1.2 |
| 10:11 ET | 100 | 1.195 |
| 10:18 ET | 100 | 1.195 |
| 10:22 ET | 251 | 1.1995 |
| 10:24 ET | 200 | 1.2 |
| 10:26 ET | 14493 | 1.175 |
| 10:27 ET | 2033 | 1.175 |
| 10:29 ET | 2300 | 1.18 |
| 10:33 ET | 2234 | 1.174 |
| 10:38 ET | 420 | 1.175 |
| 10:42 ET | 100 | 1.175 |
| 10:44 ET | 500 | 1.1799 |
| 10:47 ET | 100 | 1.18 |
| 10:54 ET | 2983 | 1.17 |
| 10:56 ET | 100 | 1.18 |
| 10:58 ET | 100 | 1.175 |
| 11:03 ET | 100 | 1.175 |
| 11:09 ET | 3420 | 1.165 |
| 11:14 ET | 500 | 1.15 |
| 11:16 ET | 4872 | 1.155 |
| 11:18 ET | 415 | 1.1598 |
| 11:20 ET | 7493 | 1.1401 |
| 11:21 ET | 3660 | 1.16 |
| 11:25 ET | 2275 | 1.1599 |
| 11:27 ET | 3660 | 1.155 |
| 11:30 ET | 1136 | 1.16 |
| 11:38 ET | 1400 | 1.1699 |
| 11:39 ET | 1200 | 1.16 |
| 11:41 ET | 2800 | 1.1693 |
| 11:43 ET | 2875 | 1.1692 |
| 11:45 ET | 3600 | 1.17 |
| 11:48 ET | 1451 | 1.17 |
| 11:50 ET | 800 | 1.17 |
| 11:59 ET | 300 | 1.17 |
| 12:01 ET | 7358 | 1.15 |
| 12:03 ET | 3300 | 1.155 |
| 12:06 ET | 10794 | 1.15 |
| 12:08 ET | 16842 | 1.1525 |
| 12:10 ET | 300 | 1.1525 |
| 12:12 ET | 4336 | 1.15 |
| 12:14 ET | 800 | 1.15 |
| 12:17 ET | 600 | 1.15 |
| 12:21 ET | 100 | 1.15 |
| 12:28 ET | 1195 | 1.15 |
| 12:30 ET | 100 | 1.145 |
| 12:32 ET | 1363 | 1.15 |
| 12:35 ET | 1122 | 1.1471 |
| 12:39 ET | 10450 | 1.13 |
| 12:42 ET | 2137 | 1.135994 |
| 12:44 ET | 5000 | 1.15 |
| 12:46 ET | 100 | 1.1449 |
| 12:48 ET | 300 | 1.15 |
| 12:50 ET | 200 | 1.15 |
| 12:53 ET | 346 | 1.1496 |
| 12:55 ET | 5129 | 1.1399 |
| 12:57 ET | 700 | 1.145 |
| 01:00 ET | 600 | 1.14 |
| 01:02 ET | 300 | 1.145 |
| 01:04 ET | 100 | 1.14 |
| 01:06 ET | 100 | 1.145 |
| 01:13 ET | 289 | 1.1492 |
| 01:15 ET | 100 | 1.145 |
| 01:18 ET | 5186 | 1.135 |
| 01:22 ET | 264 | 1.14 |
| 01:26 ET | 100 | 1.14 |
| 01:29 ET | 799 | 1.15 |
| 01:33 ET | 6453 | 1.145 |
| 01:36 ET | 1302 | 1.145 |
| 01:38 ET | 2533 | 1.145 |
| 01:40 ET | 100 | 1.145 |
| 01:42 ET | 130300 | 1.15 |
| 01:44 ET | 1309 | 1.15 |
| 01:47 ET | 2809 | 1.145 |
| 01:51 ET | 5528 | 1.1455 |
| 01:54 ET | 100 | 1.145 |
| 01:56 ET | 1281 | 1.144 |
| 02:02 ET | 306 | 1.15 |
| 02:03 ET | 4225 | 1.145 |
| 02:05 ET | 100 | 1.145 |
| 02:07 ET | 1300 | 1.145 |
| 02:09 ET | 4000 | 1.15 |
| 02:12 ET | 313 | 1.1492 |
| 02:14 ET | 100 | 1.145 |
| 02:20 ET | 200 | 1.145 |
| 02:21 ET | 100 | 1.145 |
| 02:23 ET | 4400 | 1.145 |
| 02:25 ET | 5460 | 1.15 |
| 02:27 ET | 1110 | 1.15 |
| 02:30 ET | 2400 | 1.15 |
| 02:32 ET | 2544 | 1.1587 |
| 02:34 ET | 5380 | 1.155 |
| 02:36 ET | 4527 | 1.15 |
| 02:38 ET | 1744 | 1.155 |
| 02:43 ET | 2652 | 1.15 |
| 02:45 ET | 3140 | 1.155 |
| 02:48 ET | 3880 | 1.15 |
| 02:50 ET | 1000 | 1.15 |
| 02:54 ET | 555 | 1.152 |
| 02:56 ET | 200 | 1.15 |
| 02:57 ET | 3146 | 1.15 |
| 02:59 ET | 1053 | 1.15 |
| 03:01 ET | 2456 | 1.15 |
| 03:03 ET | 821 | 1.1499 |
| 03:08 ET | 2000 | 1.149 |
| 03:12 ET | 5205 | 1.15 |
| 03:14 ET | 3100 | 1.15 |
| 03:15 ET | 1761 | 1.16 |
| 03:17 ET | 1297 | 1.155 |
| 03:19 ET | 1500 | 1.16 |
| 03:21 ET | 1400 | 1.155 |
| 03:26 ET | 1400 | 1.156 |
| 03:28 ET | 1277 | 1.15 |
| 03:32 ET | 100 | 1.145 |
| 03:37 ET | 2660 | 1.15 |
| 03:42 ET | 3500 | 1.145 |
| 03:44 ET | 1550 | 1.15 |
| 03:46 ET | 450 | 1.145 |
| 03:48 ET | 3698 | 1.15 |
| 03:50 ET | 8370 | 1.145 |
| 03:51 ET | 3910 | 1.16 |
| 03:53 ET | 1100 | 1.15 |
| 03:55 ET | 300 | 1.15 |
| 03:57 ET | 4336 | 1.15 |
| 04:00 ET | 40724 | 1.15 |
Nov 8, 2024
DJ Prelude Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co., from 11:54AM ET on Friday Nov 08, 2024 by Dow Jones
11:54AM ET on Friday Nov 08, 2024 by Dow Jones
Nov 6, 2024
Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones*DJ Prelude Therapeutics 3Q Loss/Shr 43c >PRLD, from 4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
Oct 28, 2024
DJ Prelude Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co., from 8:18AM ET on Monday Oct 28, 2024 by Dow Jones
8:18AM ET on Monday Oct 28, 2024 by Dow Jones
Oct 24, 2024
Prelude Therapeutics Presents New Data from SMARCA Degrader Portfolio at the 36th EORTC-NCI-AACR Symposium, from 7:30AM ET on Thursday Oct 24, 2024 by Dow Jones
7:30AM ET on Thursday Oct 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Prelude Therapeutics Inc | 65.5M | -0.6x | --- |
enVVeno Medical Corp | 63.9M | -2.6x | --- |
RetinalGenix Technologies Inc | 63.0M | -15.3x | --- |
Maia Biotechnology Inc | 62.9M | -1.6x | --- |
Entera Bio Ltd | 62.6M | -6.4x | --- |
IO Biotech Inc | 69.2M | -0.6x | --- |
Company Information
Prelude Therapeutics Incorporated is a clinical-stage fully integrated oncology company built on a foundation of drug discovery to deliver novel precision cancer medicines to underserved patients. It has developed a diverse pipeline consisting of multiple distinct programs: kinases, targeted protein degraders, and precision antibody drug conjugates. Its product candidates include PRT3789, PRT2527 and PRT3645. PRT3789 is a highly selective degrader of SMARCA2 protein, which along with SMARCA4, controls gene regulation through chromatin remodeling. Its CDK9 program is an essential regulator of cancer-promoting transcriptional programs, including those driven by MCL1, MYC and MYB. PRT3645 is a brain and tissue penetrant molecule that potently targets CDK4/6 with a biased selectivity for CDK4. PRT2527 is designed to be a potent and selective CDK9 inhibitor. Its MCL1 candidate, PRT1419, is designed to be a potent and selective inhibitor of the anti-apoptotic protein, MCL1.
Contact Information
- Headquarters
- 175 Innovation BoulevardWILMINGTON, DE, United States 19805
- Phone
- 302-467-1280
- Fax
- 302-658-3989
Executives
- Independent Chairman of the Board
- Paul Friedman
- President, Chief Medical Officer
- Jane Huang
- Chief Executive Officer, Founder, Director
- Krishna Vaddi
- Interim Chief Financial Officer, Chief Legal Officer, Corporate Secretary
- Bryant Lim
- Senior Vice President of Investor Relations
- Robert Doody
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $65.5M |
|---|---|
Revenue (TTM) | $3.0M |
Shares Outstanding | 55.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.53 |
EPS | $-1.77 |
Book Value | $5.64 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 21.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4,775.40% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
